AUTHORS: Bethany K Sederdahl, MPH, MD, and Anthony Sciscione, DO
Genital infection with Chlamydia trachomatis (CT) is the most prevalent sexually transmitted disease in the U.S. In women, chlamydia infection can result in cervicitis, acute urethral syndrome, endometritis, and pelvic inflammatory disease. These infections can, in turn, lead to ectopic pregnancy, infertility, and chronic pelvic pain (see Pelvic Inflammatory Disease). In men, CT infection may cause mucopurulent discharge, urethritis, epididymitis, and prostatitis. Newborns born via an infected birth canal are at risk for conjunctivitis and pneumonia. A majority of the men and women affected with CT are asymptomatic. Thus, screening tests play a very important role in detection of this infection to initiate treatment, impede disease sequelae, and prevent further transmissions.1,2
|
TABLE E1 Clinical Characteristics of Common Chlamydia trachomatis Infections
Infection | Symptoms and Signs | Presumptive Diagnosis | Definitive Diagnosis | Treatment | |
---|---|---|---|---|---|
Men | Nongonococcal urethritis | Urethral discharge, dysuria | Urethral leukocytosis; no gonococci seen | Urine or urethral NAAT | Doxycycline, 100 mg PO bid, for 7 days |
Epididymitis | Unilateral epididymal tenderness, swelling; pain; fever, presence of NGU | Urine or urethral NAAT | Urethral leukocytosis; pyuria on urinalysis | STI likely: Ceftriaxone 500 mg (1 g for individuals weighing >150 kg) IM plus doxycycline, 100 mg PO bid, for 10 days | |
If enteric organisms are suspected: | |||||
Ceftriaxone, 500 mg (1 g for individuals weighing >150 kg) IM, plus levofloxacin, 500 mg bid for 10 days | |||||
Proctitis (non-LGV) | Rectal pain, discharge and bleeding; history of receptive anal intercourse | ≥1 PMN/OIF on rectal Gram stain; no gonococci seen | Urine or urethral NAAT; rectal culture or NAAT | Ceftriaxone, 500 mg (1 g for individuals weighing >150 kg) IM, plus Doxycycline, 100 mg PO bid, for 7 days | |
Lymphogranuloma venereum proctitis | Painful, tender inguinal lymphadenopathy, fever | Groove sign | Urine, urethral, lymph node or rectal NAAT; rectal or lymph node culture; LGV-specific testing if available | Doxycycline, 100 mg PO bid, for 21 days | |
Women | Cervicitis | Mucopurulent cervical discharge; ectopy, easily induced bleeding | ≥20 PMN/OIF on cervical Gram stain | Urine or cervical NAAT | Doxycycline, 100 mg PO bid, for 7 days |
Urethritis | Dysuria, frequency; no hematuria | Pyuria on UA; negative urine Gram stain and culture | Urine, cervical, or urethral NAAT | Doxycycline, 100 mg PO bid for 7 days | |
Pelvic inflammatory disease | Lower abdominal pain, adnexal pain, cervical motion tenderness | Evidence of mucopurulent cervicitis | Urine or cervical NAAT | Outpatient: Ceftriaxone 500 mg IM as a single dose, plus doxycycline 100 mg PO bid for 14 days, with metronidazole, 500 mg PO bid for 14 days | |
Adults | Conjunctivitis | Ocular pain, redness, discharge; simultaneous genital infection | Gram stain of conjunctival swab negative for bacterial pathogens; PMNs on smear | DFA or NAAT on conjunctival swab | Doxycycline, 100 mg PO bid for 7 days |
Newborns | Conjunctivitis | Ocular pain, redness, discharge; simultaneous genital infection | Gram stain of conjunctival swab negative for bacterial pathogens; PMNs on smear | DFA or NAAT on conjunctival swab; vagina, rectum, pharynx also often positive | Erythromycin base 50 mg/kg/day, PO divided into four doses daily for 14 days; evaluate and treat parents as well |
Pneumonia | Staccato cough, tachypnea, hyperinflation | Diffuse interstitial infiltrate, eosinophilia | Nasopharyngeal NAATs or culture; MIF serology (IgM) | Erythromycin base or ethylsuccinate 50 mg/kg/day, PO divided into four doses daily for 14 days; evaluate and treat parents as well |
bid, Twice daily; DFA, Direct fluorescent antibody; IgM, immunoglobulin M; IM, intramuscular; LGV, lymphogranuloma venereum; MIF, microimmunofluorescence; MSM, men who have sex with men; NAAT, nucleic acid amplification test; NGU, nongonococcal urethritis; OIF, oil immersion field; PMN, polymorphonuclear neutrophil; PO, by mouth; STI, sexually transmitted infection; UA, urinalysis.
From Bennett JE et al: Mandell, Douglas, and Bennetts principles and practice of infectious diseases, ed 8, Philadelphia, 2015, Saunders; updated with new treatment guidelines from the Centers for Disease Control and Prevention.
Differential diagnosis depends on presenting symptoms. Some of the common differentials are listed in the following
Individuals with signs and symptoms mentioned previously should be screened for CT infection. Because majority of CT infections are asymptomatic, routine screening should be offered to individuals at risk for CT infection. In women, screening reduces the rate of PID. Annual screening is thus recommended for all sexually active women less than 25 yr of age and women at any age at risk for sexually transmitted infections. Risk factors include a new sexual partner, more than one sexual partner, individuals not in a mutually monogamous relationship, a previous or concurrent sexually transmitted disease, or working in the sex industry for profit. Screening interval is determined by any new risk for exposure since the last negative screening. The CDC recommends CT screening for all pregnant women under the age of 25 and for any pregnant woman over the age of 25 who is at increased risk for acquiring CT at their initial prenatal care visit. These same pregnant women should be screened again during the third trimester. At a minimum, annual screening is also recommended for men who have sex with men and persons with HIV.1,3
Nongonococcal urethritis, urethritis, cervicitis, conjunctivitis (except for lymphogranuloma venereum):
NOTE: Azithromycin (Pregnancy Risk Category B) is generally considered safe and effective during pregnancy and with lactation. Doxycycline is contraindicated in pregnancy.
Retreat noncompliant patients with the above regimens. If patient was initially compliant, recommended regimens include metronidazole 2 g PO in single dose plus erythromycin base 500 mg PO qid for 7 days or erythromycin ethylsuccinate 800 mg PO qid for 7 days.
A 7-day course of doxycycline (100 mg twice daily for 7 days) is superior to single-dose infection among men who have sex with men.1
Refer to infectious disease specialist if persistent infection or gynecologist if salpingitis is suspected.
Cervicitis (Related Key Topic)
Urethritis, Gonococcal (Related Key Topic)
Gonorrhea (Related Key Topic)
Urethritis, Nongonococcal (Related Key Topic)
Pelvic Inflammatory Disease (Related Key Topic)